tiprankstipranks
ValiRx Expands European Presence with BioRep Partnership
Company Announcements

ValiRx Expands European Presence with BioRep Partnership

ValiRx plc (GB:VAL) has released an update.

Don't Miss Our Christmas Offers:

ValiRx Plc, through its subsidiary Inaphaea BioLabs, has partnered with Italian biobanking service provider BioRep to enhance the distribution of its drug screening services and Patient Derived Cells in Europe. The collaboration will leverage BioRep’s logistics, sample management, and molecular biology services to expand ValiRx’s reach. The agreement includes co-marketing initiatives and royalty sharing on contracts, aiming to facilitate oncology research and sample provision in the European market.

For further insights into GB:VAL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskValiRx Unveils New Interactive Investor Website to Boost Engagement
TipRanks UK Auto-Generated NewsdeskValiRx Successfully Raises £1.57 Million in Fundraising Initiative
TipRanks UK Auto-Generated NewsdeskValiRx Announces General Meeting to Discuss Key Resolutions for Strategic Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App